Loading...

Home
ETF
RAPP

RAPP

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

RAPP News

Rapport Therapeutics Reports Q4 Earnings Miss

9h agoseekingalpha

RAPPORT THERAPEUTICS STOCK RISES 5% AFTER AWARDING CHINA RIGHTS FOR EPILEPSY MEDICATION

Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results

Rapport Partners with Tenacia for RAP-219 Development in Greater China

1d agoYahoo Finance

Rapport Therapeutics (RAPP) Receives FDA Clearance to Advance RAP-219 into Phase 3 Trials

Jan 08 2026NASDAQ.COM

Cormorant Increases Stake in Rapport Therapeutics by 251,600 Shares Worth $94.82 Million

Dec 22 2025Fool

Cormorant Increases Stake in Rapport Therapeutics by 251,600 Shares Worth $61.38 Million

Dec 22 2025NASDAQ.COM

Rapport Therapeutics, Inc. (RAPP) Sees a 9.03% Increase Over the Past Week: Key Insights to Consider

Dec 08 2025NASDAQ.COM

Valuation Assessment of Rapport Therapeutics (RAPP) Following 60% Increase in Share Price This Year

Dec 07 2025Yahoo Finance

RAP-219 Phase 2a Seizure Results and Upcoming Pivotal Trials Could Influence Investment Decisions in Rapport Therapeutics (RAPP)

Dec 06 2025Yahoo Finance

Rapport Therapeutics Reports RAP-219 Clinical Data, Significantly Reducing Seizure Frequency

Dec 05 2025Globenewswire

Rapport Therapeutics Reports RAP-219 Clinical Data, Significantly Reducing Seizure Frequency

Dec 05 2025Newsfilter

Extreme Networks Analyst Starts Coverage with Optimism; Check Out the Top 5 Initiations for Wednesday

Nov 19 2025Benzinga

Biotech Makes a Comeback: Reasons to Add These Rising Stocks to Your Portfolio Today.

Nov 03 2025MarketWatch

Biotech Stocks Surge in After-Hours Trading on Friday in Anticipation of Important Clinical Trial Announcements

Sep 22 2025NASDAQ.COM

Rapport Therapeutics, Inc. (RAPP) Shares Insights at TD Cowen's 5th Annual Summit on Novel Mechanisms in Neuropsychiatry and Epilepsy

Sep 17 2025Newsfilter